Document type:52-109F2 - Certification of interim filings - CEO (E)
Project number:03218287
Filing date:05-07-2021
This is not the latest filing of type "52-109F2 - Certification of interim filings - CEO (E)" for the IssuerShow the latest document View all the latest filings by Trillium Therapeutics Inc.